Ameriprise Financial »

Fate Therapeutics shares owned by Ameriprise Financial

Quarter-by-quarter ownership of Fate Therapeutics (FATE) shares owned by Ameriprise Financial from 13F filings

Historical chart of Ameriprise Financial investment in Fate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fate Therapeutics held by Ameriprise Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fate Therapeutics by Ameriprise Financial

Quarter filed Position value Share count Share price at filing
2024-03-31 $2.1M 284k 7.34
2023-09-30 $584k 276k 2.12
2023-06-30 $1.2M 248k 4.76
2023-03-31 $439k 77k 5.70
2022-12-31 $198k 19k 10.51
2022-09-30 $1.9M 85k 22.41
2022-06-30 $2.0M 80k 24.78
2022-03-31 $2.7M 70k 38.78
2021-12-31 $30M 512k 58.50
2021-09-30 $47M 797k 59.28
2021-06-30 $58M 668k 86.80
2021-03-31 $51M 622k 82.47
2020-12-31 $24M 265k 90.93
2020-09-30 $14M 339k 39.97
2020-06-30 $12M 354k 34.31
2020-03-31 $11M 505k 22.22
2019-12-31 $38M 2.0M 19.58
2019-09-30 $23M 1.5M 15.53
2019-06-30 $14M 703k 20.31
2018-03-31 $862k 88k 9.76